Trial Profile
The influence of liraglutide on hypoglycaemia counterregulation and pulsatile insulin secretion in type 2 diabetics
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Aug 2014
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 01 Jul 2014 Status changed from recruiting to discontinued as reported by European Clinical Trials Database record.
- 26 Sep 2012 New trial record